Larrayoz, Marta <br/><br/>
Contrasting responses of non-small cell lung cancer to antiangiogenic therapies depend on histological subtype.  [electronic resource] 

 -  EMBO molecular medicine  04 2014 
 - 539-50 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1757-4684 
<br/><br/><label>Standard No.: </label>10.1002/emmm.201303214  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Angiogenesis Inhibitors--administration & dosage<br/>Animals<br/>Antibodies, Monoclonal--administration & dosage<br/>Carcinoma, Non-Small-Cell Lung--drug therapy<br/>Female<br/>Humans<br/>Indoles--administration & dosage<br/>Mice<br/>Mice, Inbred BALB C<br/>Pyrroles--administration & dosage<br/>Sunitinib<br/>Treatment Outcome<br/>Xenograft Model Antitumor Assays